$CE

Celanese Corp

Celanese is a global chemical and specialty materials company headquartered in Irving, Texas. It produces high-performance engineered polymers for applications including automotive, medical, industrial and consumer products, and acetyl products used as intermediate chemicals across industries. Its customers include major companies in a broad range of industries. Celanese operates principally through Engineered Materials and the Acetyl Chain. Engineered Materials sells polymers such as nylon compounds, polyoxymethylene, liquid crystal polymers and thermoplastic elastomers, often through project-based customer relationships. The Acetyl Chain makes and sells acetic acid, vinyl acetate monomer, acetate tow, emulsion polymers, EVA resins and redispersible powders, among other products. It earns money by selling products directly and through distributors, with pricing influenced by product value, demand, raw material costs and industry conditions.

AlphAI earnings readThird Quarter 2026 · NOV 2Celanese Corporation Reports Third Quarter Earnings; Exceeds Third Quarter Guidance and Raises Full Year OutlookVerdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
2
0

No SEC Form 4 filings for $CE in the last 30 days.

See all $CE insider activity →
Low

Celanese Corp (CE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Celanese Corp (CE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Celanese Corporation 222 West Las Colinas Blvd. Suite 900N Irving, Texas 75039 Peter Matt Elected to Celanese Board of Directors DALLAS (November 16, 2026) - Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that Pete

Celanese Q3 Net Sales $2.6 Billion, Up 6% Year-on-Year

Celanese reported Q3 2026 net sales of $2.6B, up 6% YoY but down 7% QoQ. EPS was $0.68 GAAP and $1.65 adjusted. Operating income was $198M, adjusted EBITDA $367M. Engineering Materials sales fell 1% YoY, while Acetyl Chain sales rose 14% YoY. Operating cash flow was $538M, free cash flow $461M.

BMO raises Celanese stock price target to $58 on cost cuts

BMO Capital increased its price target for Celanese (NYSE:CE) to $58 from $56, citing cost-cutting and cash generation. The firm expects higher estimates for 2027-2028 due to growth in engineered materials, despite challenges in the acetyl chain business. Celanese reported Q3 2026 earnings of $1.65 per share, beating estimates, but revenue fell short. Other analysts have also raised price targets.

CE sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning CE (Celanese Corp). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.

Recent CE coverage spans financial news, earnings and corporate actions.

What's driving CE

AlphAI scores every news story that mentions CE with an AI model for sentiment and relevance, and aggregates insider trades from Celanese Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CE

Score
$CELowExec change· elected

Celanese Corp (CE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Celanese Corp (CE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Celanese Corporation 222 West Las Colinas Blvd. Suite 900N Irving, Texas 75039 Peter Matt Elected to Celanese Board of Directors DALLAS (November 16, 2026) - Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that Pete

BMO raises Celanese stock price target to $58 on cost cuts

BMO Capital increased its price target for Celanese (NYSE:CE) to $58 from $56, citing cost-cutting and cash generation. The firm expects higher estimates for 2027-2028 due to growth in engineered materials, despite challenges in the acetyl chain business. Celanese reported Q3 2026 earnings of $1.65 per share, beating estimates, but revenue fell short. Other analysts have also raised price targets.

KeyBanc raises Celanese stock price target on turnaround execution

KeyBanc raised its price target on Celanese (NYSE:CE) to $59 from $57, citing strong turnaround execution and improved fundamentals. The firm expects flat EBITDA but increasing EPS due to deleveraging, with free cash flow in the $700M-$800M range. Celanese's Q3 2026 earnings beat estimates, but revenue missed. Citi also raised its target to $65. Analysts highlight attractive valuation metrics.

ASX set to slide, tech stocks boost Wall Street

US markets showed mixed performance with the S&P 500 up 0.5%, Dow down 0.5%, and Nasdaq up 1%. Tech stocks like Nvidia, Broadcom, AMD, and Micron rose, while Apple fell 2% despite strong earnings due to higher memory chip costs. ASX futures indicate a 0.3% drop. Midterm elections and AI-related volatility also influenced trading.

$CEMedAI 8/10

Celanese Q3 2026 slides: specialty focus drives margin gains

Celanese (NYSE:CE) reported Q3 2026 earnings with revenue of $2.56B, missing estimates, but EPS of $1.65 beat expectations. The company highlighted strong free cash flow of $461M and raised full-year guidance to $750M-$800M. Shares rose 3.86% to $49.79. Celanese is shifting focus to high-margin specialty applications in medical and electronics, driving margin expansion.

Related tickers